Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies

Journal of General Virology

Volumn 91, Issue 3, 2010, Pages 643-652

  Serruys, Benedikte ^a   Van Houtte, Freya ^a   Farhoudi Moghadam, Ali ^a   Leroux Roels, Geert ^a   Vanlandschoot, Peter ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELL NUCLEUS; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 76849094865     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.016063-0     Document Type: Article

References (21)

1. Bruss, V. (2004). Envelopment of the hepatitis B virus nucleocapsid. Virus Res 106, 199-209.
2. Bruss, V. (2007). Hepatitis B virus morphogenesis. World J Gastroenterol 13, 65-73.
3. Butz, K., Denk, C., Fitscher, B., Crnkovic-Mertens, I., Ullmann, A., Schröder, C. H. & Hoppe-Seyler, F. (2001). Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 20, 6579-6586.
4. Deres, K., Schröder, C. H., Paessens, A., Goldmann, S., Hacker, H. J., Weber, O., Krämer, T., Niewöhner, U., Pleiss, U. & other authors (2003). Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299, 893-896.
5. Feld, J., Lee, J. Y. & Locarnini, S. (2003). New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38, 545-553.
6. Feng, Y., Kong, Y. Y., Wang, Y. & Qi, G. R. (2001). Intracellular inhibition of the replication of hepatitis B virus by hammerhead ribozymes. J Gastroenterol Hepatol 16, 1125-1130.
7. Gordien, E., Rosmorduc, O., Peltekian, C., Garreau, F., Brechot, C. & Kremsdorf, D. (2001). Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol 75, 2684-2691.
8. Hilleman, M. R. (2003). Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 21, 4626-4649.
9. Ji, W. & Si, C. W. (1997). Inhibition of hepatitis B virus by retroviral vectors expressing antisense RNA. J Viral Hepat 4, 167-173.
10. Kann, M., Schmitz, A. & Rabe, B. (2007). Intracellular transport of hepatitis B virus. World J Gastroenterol 13, 39-47.
11. Kim, T. H., Cho, E. Y., Oh, H. J., Choi, C. S., Kim, J. W., Moon, H. B. & Kim, H. C. (2006). The degrees of hepatocyte cytoplasmic expression of hepatitis B core antigen correlate with histologic activity of liver disease in the young patients with chronic hepatitis B infection. J Korean Med Sci 21, 279-283.
12. Lavanchy, D. (2004). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11, 97-107.
13. Rabe, B., Vlachou, A., Pante, N., Helenius, A. & Kann, M. (2003). Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A 100, 9849-9854.
14. Rosmorduc, O., Sirma, H., Soussan, P., Gordien, E., Lebon, P., Horisberger, M., Brechot, C. & Kremsdorf, D. (1999). Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J Gen Virol 80, 1253-1262.
15. Seeger, C., Zoulim, F. & Mason, W. S. (2007). Hepadnaviruses. In Fields Virology, 5th edn, pp. 2977-3029. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams and Wilkins.
16. Serinoz, E., Varli, M., Erden, E., Cinar, K., Kansu, A., Uzunalimoglu, O., Yurdaydin, C. & Bozkaya, H. (2003). Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load. J Clin Gastroenterol 36, 269-272.
17. Serruys, B., Van Houtte, F., Verbrugghe, P., Leroux-Roels, G. & Vanlandschoot, P. (2009). Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice. Hepatology 49, 39-49.
18. Tuttleman, J. S., Pourcel, C. & Summers, J. (1986). Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47, 451-460.
19. Xu, R., Cai, K., Zheng, D., Ma, H., Xu, S. & Fan, S. T. (2003). Molecular therapeutics of HBV. Curr Gene Ther 3, 341-355.
20. Yamamoto, M., Hayashi, N., Takehara, T., Ueda, K., Mita, E., Tatsumi, T., Sasaki, Y., Kasahara, A. & Hori, M. (1999). Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells. Hepatology 30, 300-307.
21. Ying, C., De Clercq, E. & Neyts, J. (2003). Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun 309, 482-484.